C6orf89 Activators predominantly operate via the modulation of histone deacetylase activity and cellular signaling pathways like MAPK, PKA, and PI3K/Akt. Histone deacetylase inhibitors like Valproic Acid, TSA, and SAHA can act to modify the epigenetic landscape, thereby increasing the transcription of genes that contribute to the activation of C6orf89. Their specific influence lies in increasing acetylation levels, altering the chromatin structure and making it more accessible for transcription factors and other regulatory elements. These changes can foster an environment where C6orf89 is more likely to be activated.
In contrast, chemicals like Forskolin and EGF engage more directly with cellular signaling pathways. Forskolin, for example, increases intracellular cAMP levels, leading to PKA activation. PKA has been implicated in epithelial cell proliferation, a process where C6orf89 plays a role. EGF, via its activation of the MAPK pathway, can also influence epithelial cell proliferation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Inhibits histone deacetylases, thereby augmenting histone acetylation levels. This can lead to the activation of genes that subsequently activate C6orf89. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
HDAC inhibitor that increases histone acetylation and could thereby induce the upregulation of C6orf89 through epigenetic changes. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Another HDAC inhibitor, it can positively regulate the histone deacetylase activity, indirectly facilitating C6orf89 function. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Regulates gene expression and can stimulate epithelial cell proliferation, a process in which C6orf89 is involved. | ||||||
Anacardic Acid | 16611-84-0 | sc-202463 sc-202463A | 5 mg 25 mg | $102.00 $204.00 | 13 | |
Inhibits histone acetyltransferase, but in doing so can cause compensatory effects that might activate C6orf89. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates PKC which can influence pathways leading to epithelial cell proliferation, indirectly influencing C6orf89. | ||||||